Silo Pharma Inc.

OTCQB: SILO

Company Logo

Company Overview

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.

Financial Highlights

$72,102

Revenue (ttm)

$66,260

Gross Profit (ttm)

-$1.61

Diluted EPS (ttm)

Management Team

Mr. Eric Weisblum
Chairman, Pres & CEO

Mr. Daniel E. Ryweck
Chief Financial Officer

Dr. James S. Kuo M.B.A., M.D.
VP of R&D

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$307,488,811

Shares Outstanding
85,176,956

Shares Short (% of Float)
()

Insider Ownership
15%